Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progression-Reference-Cited by-同舟云学术

Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progression

Published:2020-08-17 Issue:14 Volume:80 Page:1253-1262
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Liu Wennuan¹²,Hou Jun¹,Petkewicz Jacqueline³,Na Rong¹^ORCID,Wang Chi‐Hsiung¹²,Sun Jishan¹²,Gallagher Johnie¹,Bogachkov Yedida Y.¹,Swenson Laura¹,Regner MaryAnn⁴,Resurreccion W. Kyle¹,Isaacs William B.⁵^ORCID,Brendler Charles B.¹²,Crawford Susan¹²,Zheng S. Lilly¹²,Helfand Brian T.¹²³,Xu Jianfeng¹²^ORCID

Affiliation:

1. Program for Personalized Cancer CareNorthShore University HealthSystemEvanston Illinois

2. Department of SurgeryNorthShore University HealthSystemEvanston Illinois

3. John and Carol Walter Center for Urological HealthNorthShore University HealthSystemEvanston Illinois

4. Department of PathologyNorthShore University HealthSystemEvanston Illinois

5. Department of Urology and OncologyJohns Hopkins School of MedicineBaltimore Maryland

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24057